Главная О вакцине

Научные публикации о вакцине

20.04.2023

Immunogenicity and In Vivo Protective Effects of Recombinant Nucleocapsid-Based SARS-CoV-2 Vaccine Convacell®

30.09.2022

Вакцина на основе N-белка SARS-CoV-2 формирует выраженный Т-клеточный иммунитет на N-белок новых штаммов

Научные публикации про N-белок

28.04.2023

The role of SARS-CoV-2 nucleocapsid protein in antiviral immunity and vaccine development

28.04.2023

The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and diagnostics

03.02.2023

Cell surface SARS-CoV-2 nucleocapsid protein modulates innate and adaptive immunity

02.02.2023

SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies

06.09.2022

Nucleocapsid as a next-generation COVID-19 vaccine candidate

05.07.2022

Next-generation SARS-CoV-2 nucleocapsid-based vaccines may provide optimal protection against infection

03.07.2022

Nucleocapsid as a next-generation COVID-19 vaccine candidate

09.05.2022

Nucleocapsid protein of SARS-CoV-2 is a potential target for developing new generation of vaccine

24.09.2021

Targeting intra-viral conserved nucleocapsid (N) proteins as novel vaccines against SARS-CoVs

15.07.2021

Cutting Edge: Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity

24.04.2021

A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques

28.10.2020

Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets

16.06.2020

The Nucleocapsid Protein of SARS–CoV-2: a Target for Vaccine Development